Abstract
We examined the associations between pesticide exposure, genetic polymorphisms for NAD(P)H:quinone oxidoreductase I (NQO1) and superoxide dismutase 2 (SOD2), and urinary bladder cancer risk among male agricultural workers in Egypt.
We used logistic regression to analyze data from a multi-center case-control study and estimate adjusted odds ratio (OR) and 95% CI (confidence interval)
Exposure to pesticides was associated with increased bladder cancer risk (1.68 (1.23–2.29)) in a dose-dependent manner. The association was slightly stronger for urothelial (1.79 (1.25–2.56) than for squamous cell carcinoma (1.55 (1.03–2.31)), and among participants with combined genotypes for low NQO1 and high SOD2 (2.14 (1.19–3.85) activities as compared to those with high NQO1 and low SOD2 genotypes (1.53 (0.73–3.25)).
In conclusion, among male agricultural workers in Egypt, pesticide exposure is associated with bladder cancer risk and possibly modulated by genetic polymorphism.
Keywords: Pesticides, Bladder cancer, Gene polymorphism, Epidemiology, Egypt, Agricultural workers
Introduction
Tobacco smoking, history of infection with Shistosoma hematobium (SH), and occupational chemical exposures have been well-established as risk factors for urinary bladder cancer;1–6 namely the two predominant types (95%), urothelial cell carcinoma (UC) and squamous cell carcinoma (SCC). The association of farming as an occupation with bladder cancer risk was examined by several investigators, but the results are inconsistent; some studies found an increased risk,7–11 while others reported decreased risk.12,13 Agricultural workers are exposed to chemicals including aromatic amines and polycyclic aromatic hydrocarbon, which were consistently found to increase the risk for bladder cancer,3,4,6 and pesticides; the latter encompasses an array of compounds with different metabolic pathways and actions.14 Indeed, some pesticides are considered probable or possible carcinogens,15 and few were found to be associated with increased risk of bladder cancer,16–19 but not others.20–21
Considering that metabolism of some pesticides can lead to an increase in the levels of reactive oxygen species (ROS),14,22,23 Investigators have examined the roles of polymorphism in genes encoding for enzymes that play key roles in protecting the cells from oxidative injury, one of the potential mechanism underlying carcinogenesis. Among the several genetic variants that were studied in different malignancies24–26 are those that code for two enzymes, NAD(P)H:quinone oxidoreductase I (NQO1)27,28 and superoxide dismutase 2 (SOD2).29 A transition from C→T at nucleotide 609 of NQO1 (rs1800566) and in exon 2 of SOD2 (rs4880) results in proline to serine and alanine to valine substitution, respectively; changes in the enzyme structures lead to decrease in their activities,30,31 and thus increase in oxidative stress and cell susceptibility. So far, the studies aimed at investigating the associations of genetic susceptibility and environmental exposures with bladder cancer risk have focused mainly on gene interaction with tobacco smoking; very few studies addressed NQO1 and SOD2 genotypes and pesticide exposures. In addition these investigations have been conducted among populations where UC is the predominant (~90%) type of primary bladder malignancy, and they have yielded conflicting results.32–41
Using data from our multicenter case-control study of bladder cancer in Egypt where more than 30% of the cases are of the SCC type,42 we recently found that Egyptian male agricultural workers have increased odds of developing bladder cancer as compared to other workers7, after adjustment for smoking and SH infection history. We also found that genetic polymorphisms in NQO1 and SOD2 modulate bladder cancer risk associated with smoking and history of SH infection.43 In the present study, we used the same population to examine: 1) the associations between bladder cancer risk and pesticide exposure among male agricultural workers; and 2) to investigate potential interactions between such exposures and genetic polymorphism of NQO1 and SOD2.
Methods
We analyzed data from a multicenter case control study conducted in Egypt between 2006 and 2011. The study was approved by the Institutional Review Boards of the three recruitment sites described below, Egypt’s Ministry of Health, the University of Maryland Baltimore, and Georgetown University.
Study Population
Recruitment for the study population were previously described in detail.7,42 Briefly, cases were recruited from three referral cancer centers that serve a large area of Egypt: the National Cancer Institute of Cairo University, the Minia Oncology Center, and the South Egypt Cancer Center in Assiut. The diagnosis of primary urinary bladder cancer was ascertained by one of the study’s two pathologists. We only included primary cases classified as UC or SCC in the present analyses. Healthy controls were randomly selected to frequency-match the cumulative groups of cases by sex, five-year age groups, governorate (province) of current residence, and urban/rural place of residence as self-reported.42
After consenting, cases and controls were questioned face-to-face by trained interviewers, who collected data on socio-demographic characteristics, occupational and environmental exposure histories including pesticide exposure, frequency, and duration, tobacco smoking (including cigarettes and waterpipes), and medical histories including history of SH infection. Blood specimens were drawn and processed for DNA extraction.
Of the 3,427 presumed bladder cancer cases who were eligible, 84% agreed to participate in the study; and of the 2,792 eligible controls approached, 97% agreed. Among the cases confirmed by the pathologist as UC or SCC, 1,525 were males matched to 2069 controls. For the present study, we included only those males who reported farming as an occupation (953 cases and 881 controls). Because of lack of funding, genotyping was carried out on 810 controls and 1356 cases only. Among those genotyped, 822 were agricultural workers, the majority of whom (N=777, comprising 419 cases and 358 controls) was from rural south Egypt.
Genotyping
DNA was extracted from buffy coats using the QIAamp DNA Mini Kits (Qiagen, Valencia, CA, USA). Genotyping for NQO1 Pro187Ser polymorphism (rs1800566) and SOD2 Ala-9Val polymorphism (rs4880) was performed using TaqMan allelic discrimination assays (Applied Biosystems), with a successful genotyping rate of 99% or higher, and genotype concordance among 10% of blind quality control duplicates of > 99.
Variables
The independent variables of interest were occupational exposure to pesticides (yes/no), frequency of pesticide exposure (categorical), and duration of exposure in years (continuous and categorical). Based on the distribution of the exposure duration, we divided it into four categories, never, ≤ 20 years, > 20 but ≤ 40 years, and > 40years. The outcome variable was primary bladder cancer or its subtypes (SCC or UC) case versus control. Covariates that were examined and included in the analyses were education, tobacco smoking history (either cigarettes or waterpipes alone, or combined), environmental tobacco smoke (ETS) exposure, and SH infection history. Regarding area of residence, Egypt has 27 governorates that are relatively homogenous within the broad regions (North and South). Because we had few cases from some of the governorates, we grouped the area of residence in two categories, North and South, for adjustment in the analyses, in addition to adjusting for urban versus rural. Furthermore, we generated four categories of age interval (≤ 45; 45 < ≤55; 55< ≤ 65; and > 65 years) for descriptive analyses, and regrouped them into three categories for stratified analyses. For the NQO1 genotype, the main polymorphisms of interest were CC, TC, and TT, encoding for high, intermediate and low activity, respectively. Because the number of specimen with TT for NQO1 was very small, TT and TC were combined. For the SOD2 genotype, the polymorphisms of interest were CC, TC, and TT, encoding respectively for high, intermediate, and low activity. We also generated two variables, one for combined NQO1 (TT or TC) with SOD2 (CC or TC), and another for combined NQO1 (CC) with SOD2 (TT).
Statistical Analyses
We used descriptive analyses to compare socio-demographic characteristics, SH infection history, and exposure to pesticides and its frequency and duration between cases and controls; Chi square and Student’s t test were used to compare categorical and continuous variables, respectively.
To assess the relationship between pesticides exposure and bladder cancer, we conducted separate analyses for each of the exposure parameter, i.e., exposure (yes/no), frequency, and duration. We used logistic regression to estimate odds ratios (OR) and 95% confidence interval (CI) for associations between independent variables and covariates, and bladder cancer risk. We tested each covariate for potential confounding or effect modification of the association between independent variable and outcome. In the final models we adjusted for significant covariates (education, tobacco smoke, SH infection history, and ETS) and the matching variables, age and area of residence (north versus south and urban versus rural). We used polytomous regression to simultaneously examine the associations between pesticides exposure and UC and SCC risk. In addition we stratified the sample by age interval (≤ 55; 55 < ≤ 65; and > 65) and performed analyses of pesticides exposure and its duration and risk of bladder cancer for each of the strata.
The analyses for gene polymorphisms and their interactions with pesticides were limited to those male agricultural workers from rural south Egypt, and thus were not adjusted for area of residence. The dataset(s) that were used in final analyses did not include missing variables, or in the case of the genotypes those with undetermined results, and therefore the sample sizes indicated in the tables might slightly differ from the size of the original sample. All statistical analyses were performed using SAS version 9.2 software.
Results
In our study population, we had 953 primary urinary bladder carcinoma confirmed as UC or SCC cases, and 881 controls, all of whom reported being agricultural workers. Their characteristics are shown in table 1. The majority was from rural south Egypt. Less than 20% of the cases and the controls never smoked.
Table 1.
Characteristic/Exposure | All Agricultural Workers | Genotyped Agricultural Workers* | ||
---|---|---|---|---|
| ||||
Controls N=881 N (%) |
Cases N=953 N (%) |
Controls N=358 N (%) |
Cases N= 419 N (%) |
|
| ||||
Mean age ± SD | 60.2±11.0 | 60.7±10.3 | 58.5±11.7 | 59.6±10.4 |
| ||||
Age group | ||||
≤ 45 | 91 (10.3%) | 71 (7.5%) | 56 (15.6%) | 38 (9.1%) |
45 < ≤ 55 | 227 (25.8%) | 223 (23.4%) | 98 (27.4%) | 109 (26.0%) |
55 < ≤ 65 | 278 (31.6%) | 329 (34.5%) | 103 (28.8% | 143 (34.1%) |
> 65 | 285 (32.3%) | 330 (34.6%) | 101 (28.2%) | 129 (30.8%) |
| ||||
Residence | ||||
North | 41 (4.6) | 54 (5.7) | - | - |
South | 840 (95.3) | 899 (94.3) | 358 (100%) | 419 (100%) |
Urban | 9 (1.0) | 44 (4.6) | - | - |
Rural | 872 (99.0) | 909 (95.4) | 358 (100%) | 419 (100%) |
| ||||
Education | ||||
None | 632 (71.7) | 779 (81.8) | 271 (75.7) | 333 (79.7%) |
Some & higher | 249 (28.3) | 173 (18.2) | 87 (24.3%) | 85 (20.3%) |
Missing | 1 | 1 | ||
| ||||
Tobacco smoke | ||||
Never | 161 (18.3) | 158 (16.6) | 63 (17.6%) | 60 (14.3%) |
Waterpipe only | 115 (13.0) | 117 (12.3) | 40 (11.2%) | 52 (12.4%) |
Cigarette only | 541 (61.4) | 547 (57.4) | 227 (63.4%) | 243 (58.0%) |
Both | 64 (7.3) | 131 (13.7) | 28 (7.8%) | 64 (15.3%) |
| ||||
ETS∞ | ||||
No | 53 (32.9%) | 34 (21.5%) | 25 (39.7%) | 14 (23.3%) |
Yes | 108 (67.1%) | 124 (78.5%) | 38 (60.3%) | 46 (73.7%) |
| ||||
SH Infection history$ | ||||
No | 387 (43.9) | 361 (37.9) | 184 (51.4%) | 140 (33.4%) |
Yes | 436 (49.5) | 540 (56.6) | 157 (43.8%) | 256 (61.1%) |
Do not know | 58 (6.6) | 52 (5.5) | 17 (4.8%) | 23 (5.5%) |
| ||||
NQO1¶ genotype& | ||||
TT@ | 19 (5.3%) | 22 (5.3%) | ||
TC | 127 (35.8%) | 146 (35.2%) | ||
CC | 209 (58.9%) | 247 (59.5%) | ||
Undetermined | 3 | 4 | ||
| ||||
SOD2¶ genotype& | ||||
TT | 109 (30.6%) | 127 (30.7%) | ||
TC | 160 (45.0%) | 188 (45.4%) | ||
CC | 87 (24.4%) | 99 (23.9%) | ||
Undetermined | 2 | 5 |
Sample was from rural south Egypt;
Environmental tobacco smoke;
Shistosoma hematobium (SH) infection;
NQO1 (NAD(P)H:Quinone Oxidoreductase); SOD2 (Superoxide Dismutase);
TT, TC, and CC, represent the variants of the genes that code respectively for the least active, intermediate, and more active forms of either enzyme;
p= 0.98 for comparing cases with controls using chi square.
Among agricultural workers for whom DNA specimen were genotyped for NQO1 and SOD2, there were 419 cases and 358 controls who resided in rural south Egypt. The characteristics of this subset were comparable to those of the larger sample of agricultural workers (Table 1). The distributions of the CC, TC, and TT genotypes for NQO1 and SOD2 were similar among cases and controls (p= 0.98) (Table 1).
As shown in table 2, more cases than controls were exposed to pesticides (56.7% versus 51.3% in the large sample) and for longer duration (35.3 versus 29.1 years). Exposure to pesticides was associated with increased odds of having bladder cancer among male agricultural workers, even after adjustment for tobacco smoke, SH history, and other covariates, albeit not statistically significant (OR (95% CI), 1.16 (0.95–1.41)); however, there were significant trends with increased frequency (p = 0.04) and more so with duration of exposure (p < 0.0001). We found that the longer the duration of pesticide exposure, the higher were the odds of developing bladder cancer; the OR (95% CI) for over 40 years of exposure was 2.18 (1.62–2.95), higher than the OR for an exposure duration between 20 and 40 years (1.14 (0.87–1.50)) (Table 2). We also found that adjusted ORs were 1.26 (1.01–1.58) and 1.01 (0.77–1.31), for UC and SCC, respectively, in the large sample of agricultural workers.
Table 2.
Pesticide Exposure | All Male Agricultural Workers | Genotyped Agricultural Workers from Rural South Egypt | ||||
---|---|---|---|---|---|---|
| ||||||
Controls N=881 N (%) |
Cases N=953 N (%) |
Adjusted* OR and (95% CI) |
Controls N=358 N (%) |
Cases N=419 N (%) |
Adjusted** OR (95% CI) |
|
| ||||||
Exposure | ||||||
No | 429 (48.7) | 413 (43.3) | Ref | 190 (53.1%) | 155 (37.0%) | Ref |
Yes | 452 (51.3) | 540 (56.7) | 1.16 (0.95–1.41) | 168 (46.9%) | 264 (63.0%) | 1.68 (1.23–2.29) |
| ||||||
Frequency | ||||||
None | 429 (48.7) | 413 (43.3) | Ref | 190 (53.1%) | 155 (37.0%) | Ref |
< once per month | 326 (37.0) | 395 (41.4) | 1.16 (0.94–1.44) | 138 (38.5%) | 190 (45.4%) | 1.44 (1.04–2.00) |
≥ once per month | 103 (11.7) | 138 (14.5) | 1.33 (0.98–1.81) | 25 (7.0%) | 71 (16.9%) | 3.24 (1.90–5.53) |
Missing | 23 (2.6) | 7(0.8) | 5 (1.4%) | 3 (0.7%) | ||
| ||||||
P for trend | 0.04 | P for trend | < 0.0001 | |||
| ||||||
Mean Duration ± SD | 29.1±15.5 | 35.3±16.4 | p < 0.0001 | 25.6±16.1 | 32.4±16.6 | <0.0001 |
| ||||||
Duration | ||||||
None | 429 (48.7) | 413 (43.3) | Ref | 190 (53.1%) | 155 (37.0%) | Ref |
≤ 20 years | 144 (16.3) | 109 (11.4) | 0.77 (0.57–1.04) | 69 (19.3%) | 69 (16.5%) | 1.10 (0.72–1.68) |
>20 but ≤40 years | 156 (17.6) | 186 (19.5) | 1.14 (0.87–1.50) | 43 (12.0%) | 90 (21.5%) | 2.39 (1.51–3.80) |
> 40 years | 93 (10.4) | 213 (22.4) | 2.18 (1.62–2.95) | 29 (8.1%) | 84 (20.0%) | 3.03 (1.82–5.04) |
Missing | 63 (7.0) | 32 (3.4) | 27 (7.5%) | 21 (5%) | ||
| ||||||
P for trend | < 0.0001 | P for trend | < 0.0001 |
Odds ratios (95% confidence interval) adjusted for education, tobacco smoke, SH infection history, environmental tobacco smoke, age (continuous), and area of residence;
adjusted for all the above except for area of residence
Among participants who were genotyped and lived in rural south Egypt, the adjusted OR for having bladder cancer was greater (1.68 (1.23–2.29)) than the OR among all agricultural workers (1.16 (0.95–1.41)) (Table 2), but like among the latter it significantly increased with the exposure frequency and duration (p for trend < 0.0001).
Whether in the bivariate or multivariable analyses, SOD2 and NQO1 genotypes were not statistically significantly associated with bladder cancer risk. We performed multivariable regression analyses where we included pesticide exposure, genotype, their interaction term, and covariates to estimate the association between pesticide exposure and cancer risk separately among those with high or low activity enzyme genotypes, and the significance of the interaction. Table 3 shows the adjusted estimates of associations between pesticide exposure and bladder cancer in different strata of genotypes.
Table 3.
All Cases | SCC& N = 164 | UC& N = 255 | ||||
---|---|---|---|---|---|---|
Genotype | Exposure | Control | Case | Adjusted Odds Ratio (95% Confidence Interval)* | ||
All genotypes | No Yes |
190 168 |
155 264 |
Ref 1.68 (1.23–2.29) |
Ref 1.55 (1.03–2.31) |
Ref 1.79 (1.25–2.56) |
Multivariable Regression Models with Interaction | ||||||
NQO1 (TT or TC)@ | No Yes |
83 63 |
65 103 |
Ref 1.94 (1.20–3.14) |
Ref 1.73 (0.91–3.17) |
Ref 2.10 (1.21–3.64) |
NQO1 (CC) | No Yes |
105 104 |
88 159 |
Ref 1.49 (0.99–2.22) |
Ref 1.40 (0.83–2.36) |
Ref 1.57 (0.98–2.50) |
Interaction p-value$ | 0.40 | 0.63 | 0.42 | |||
SOD2 (TT) | No Yes |
50 59 |
39 88 |
Ref 1.68 (1.02–2.79) |
Ref 1.75 (0.90–3.39) |
Ref 1.64 (0.91–2.94) |
SOD2 (TC) | No Yes |
93 67 |
78 110 |
Ref 1.71 (1.25–2.34) |
Ref 1.58 (1.05–2.37) |
Ref 1.82 (1.27–2.62) |
SOD2 (CC) | No yes |
46 41 |
35 64 |
Ref 1.74 (1.02–2.99) |
Ref 1.43 (0.71–2.86) |
2.03 (1.08–3.79) |
Interaction p-value | 0.93 | 0.71 | 0.66 | |||
NQO1 (TT or TC) and SOD2 (CC or TC) | No Yes |
60 38 |
47 71 |
Ref 2.14 (1.19–3.85) |
Ref 1.71 (0.80–3.65) |
Ref 2.46 (1.26–4.80) |
NQO1 (CC) and SOD2 (TT) | No Yes |
27 34 |
22 56 |
Ref 1.53 (0.73–3.25) |
Ref 1.28 (0.50–3.29) |
Ref 1.75 (0.72–4.27) |
Interaction p-value | 0.48 | 0.63 | 0.55 |
Squamous cell carcinoma (SCC) and urothelial cell carcinoma (UC) the risks of which were estimated using polytomous regression;
Adjusted for education, tobacco smoke, SH infection history, environmental tobacco smoke, and age (continuous);
TT, TC, and CC, represent the variants of the genes that code respectively for the least active, intermediate, and more active forms of either NQO1 or SOD2;
P-value for difference between genotypes with respect to effect of pesticide on bladder cancer risk.
Exposure to pesticides was associated with increased odds of having bladder cancer regardless of the genotype, albeit such increases varied in magnitude and statistical significance. For NQO1, the odds ratios were slightly higher among those with low (TT) or intermediate (TC) activity (1.94 (1.20–3.14)) as compared to those with high activity (CC) (1.49 (0.99–2.22)), while for the SOD2 strata, the odds ratios were not different between the most active form (CC) (1.74 (1.02–2.99)) of the enzyme as compared to the least active (TT) (1.68 (1.02–2.79)). The interaction term for pesticide exposure with either genotype was not statistically significant (p = 0.40 and 0.93, for NQO1and SOD2, respectively) (Table 3).
Exposure to pesticides was associated with increased odds of having either type of bladder cancer, and the association was somewhat stronger for UC than for SCC (OR (95% CI) 1.79 (1.25–2.56)) versus (1.55 (1.03–2.31)); this pattern was consistently seen across the different genotypes, although the differences across the two cancer subtypes were not statistically significant (Table 3).
We also examined the effects of pesticide exposure on bladder cancer risk among those with combined genotypes: low and intermediate activity for NQO1 (TT orTC) with high and intermediate activity for SOD2 (CC or TC) versus high activity for NQO1(CC) combined with low activity for SOD2 (TT). Table 3 shows that among participants with the former combination the OR for having either type of bladder cancer was greater (2.14 (1.19–3.85)) than the OR among those with the former (1.53 (0.73–3.25)), and it was slightly higher than the ORs observed separately with either the low and intermediate activities NQO1 (TT and TC) (1.94 (1.20–3.14)) or the high activity SOD2 (CC) (1.74 (1.02–2.99)) (Table 3).
To reduce residual confounding by age, despite adjustment for it, we stratified the sample by age group and assessed the duration of pesticide exposure among different strata. The adjusted OR (95% CI) for being exposed for ≥ 40 years were 2.94 (1.12–7.75), 2.22 (1.36–3.62), and 2.01 (1.30–3.11) for those who were ≤ 55, 55 < ≤ 65, and > 65 year-olds, respectively.
Discussion
We examined the associations between pesticide exposure and bladder cancer risk among male agricultural workers in Egypt. We found that exposure to pesticides increased the odds of having bladder cancer, in a dose-dependent manner (the longer the exposure the greater were the odds), even after adjustment for other known risk factors such as tobacco smoke and SH infection history. The association between pesticide exposure and bladder cancer risk was somewhat stronger for the UC than the SCC type, but the difference between the two subtypes was not statistically significant. Furthermore, the increase in the odds for this malignancy associated with pesticide exposure was greater for those with low or intermediate activity than high activity genotype for the enzyme NQO1.
Our finding that exposure to pesticides is positively associated with increased bladder cancer risk are consistent with some of the previously reported results.16–19 The fact that increased frequency and duration of exposure were positively associated with bladder cancer is novel and provides further support for such an association. Indeed, some pesticides are known to be associated with malignancies,4,15,44–46 and a few were found to be associated with bladder cancer;16–19 albeit the association was not statistically always significant.16,18
We observed that pesticide exposure was statistically significantly associated with both types of bladder cancer, SCC and UC. Although the association estimates were not statistically significantly different between the two subtypes, the ORs for UC risk was consistently higher than that of SCC across all genotypes analyzed, and the risk for the former was more frequently statistically significant (Table 3). The inconsistencies in significance could potentially be attributed to small sample size; SCC cases being fewer than UC.
We also found the OR of the association between pesticides and bladder malignancy to be higher among participants with genotypes coding for low and intermediate enzyme activity (TT and TC) as compared to those coding for high activity (CC) NQO1 (Table 3). Previous studies have reported that this genetic polymorphism in NQO1 leads to different susceptibility to develop bladder cancer risk,28,32,33,30,35,41 by modifying the risk of cigarette smoking.35,37,39 Our study is the first to address NQO1 genotype interaction with pesticide exposures.
Several investigators, including ourselves, examined SOD2 genotype and bladder cancer risk relationships,34,36,38,43 but the focus was on gene interaction with smoking. The present study is the first to address SOD2 polymorphism interaction with pesticide exposure and bladder cancer risk. We found with SOD2 genotypes somewhat the reverse of our finding with NQO1, especially for UC risk; that is, genotypes for high and intermediate enzyme activity (CC or TC) were associated with greater odds of having bladder cancer than the genotype with low activity among pesticide-exposed agricultural workers (Table 3). The increased risk of cancer with the active form of SOD2 genotype, although unexpected, was previously reported in a study of prostate cancer, smoking and vitamin E intake.47 A possible explanation is that the active form of SOD2 can lead to an increase in intermediate metabolites of ROS with potentially stronger carcinogenic effects than the original substrate; active forms of SOD2 lead to production of hydrogen peroxide (H2O2) which, in turn can damage DNA and participate in carcinogenesis.48,49 Indeed, such a mechanism was demonstrated for the enzymes encoded by gene variants of the glutathione S-transferase,50,51 and for catechol-O-methyltransferase.52 Our finding that agricultural workers with combined low activity NQO1 and high activity SOD2 genotypes had slightly higher risk than those with either one alone can possibly be due to an accumulation of ROS as results of its increased production by an active SOD2 and decreased removal by a less active NQO1.
The associations between bladder cancer risk and pesticides was stronger in the sample restricted to south rural Egypt (1.68 (1.23–2.29)) as compared to the main sample (1.16 (0.95–1.41)); and that was mostly driven by a proportion of pesticides-exposed cases from this area (63%) that is larger than that in the sample from all over Egypt (56%).
One of our study limitations is that we did not inquire about the specific types of pesticides that were used in agriculture. In a previous study, Ezzat et al.45 reported a long list of pesticides to which agricultural workers are exposed in Egypt; most of the major chemical categories are included, and one can assume that agricultural workers are exposed to a mixture of chemicals. Our study is one of the largest case-control studies reported on bladder cancer malignancy and pesticides, and where we were able to address its heterogeneity by examining UC and SCC separately.
The genetic analyses and gene-environment interaction analysis were performed on a smaller sample that was restricted to the rural south area, and thus the results might not be representative of the general study population. The distributions of NQO1 and SOD2 alleles among cases and controls of our restricted sample were similar to those we observed in a larger sample of genotyped cases and controls we investigated for interaction between these genes and smoking and SH infection.43
In conclusion, we found that male agricultural workers in Egypt may be at higher risk than other males for developing bladder cancer, a risk that was associated with pesticide exposures and to which contribution by susceptible genetic backgrounds is possible. Future research is needed to address the pathogenetic mechanisms underlying the pathways of carcinogenesis from exposure to specific pesticides.
Acknowledgments
This study was supported by a grant from the National Cancer Institute, National Institutes of Health (R01-CA115618 to CAL)
The authors thank the Ministry of Health and Population of Egypt, and the National Cancer Institute of Cairo University, the Minia Oncology Center, and the South Egypt Cancer Center in Assiut for supporting the study. We are also indebted to the many interviewers, translators, drivers, and other support personnel who made the study possible through their dedicated work. Special thanks to Drs. Sameera Ezzat and Tamer Hifnawy for their early contribution in recruiting participants, to Drs. Iman Gouda and Iman Loay for confirming all histopathological cases, to Drs. Mohamed S. Zaghloul and Mohamed A. Abdel-Aziz, for facilitating access to different recruitment sites.
References
- 1.Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND. Bladder cancer risk from occupational and environmental exposures. Urol Oncol. 2012;30:199–211. doi: 10.1016/j.urolonc.2011.10.010. [DOI] [PubMed] [Google Scholar]
- 2.Jankovi S, Radosavljevi V. Risk factors for bladder cancer. Tumori. 2007;93:4–12. doi: 10.1177/030089160709300102. [DOI] [PubMed] [Google Scholar]
- 3.Siemiatycki J, Richardson L, Straif K, et al. Listing Occupational Carcinogens. Environ Health Perspect. 2004;112:1447–1459. doi: 10.1289/ehp.7047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Talaska G. Aromatic Amines and Human Urinary Bladder Cancer: Exposure Sources and Epidemiology. J Environ Sci Health Part C. 2003;21:29–43. doi: 10.1081/GNC-120021372. [DOI] [PubMed] [Google Scholar]
- 5.Negri E, La Vecchia C. Epidemiology and prevention of bladder cancer. Eur J Cancer Prev. 2001;10:7–14. doi: 10.1097/00008469-200102000-00002. [DOI] [PubMed] [Google Scholar]
- 6.Boffetta P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control. 1997;8:444–472. doi: 10.1023/a:1018465507029. [DOI] [PubMed] [Google Scholar]
- 7.Amr S, Dawson R, Saleh DA, et al. Agricultural Workers and Urinary Bladder Cancer Risk in Egypt. Arch Environ Occup Health. doi: 10.1080/19338244.2012.719556. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cassidy A, Wang W, Wu X, Lin J. Risk of urinary bladder cancer: A case-control analysis of industry and occupation. BMC Cancer. 2009;9:443–450. doi: 10.1186/1471-2407-9-443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dryson E, ‘t Mannetje A, Walls C, et al. Case-control study of high risk occupations for bladder cancer in New Zealand. Int J Cancer. 2008;122:1340–1346. doi: 10.1002/ijc.23194. [DOI] [PubMed] [Google Scholar]
- 10.Settimi L, Comba P, Carrieri P, et al. Cancer Risk Among Female Agricultural Workers: A Multi-Center Case-Control Study. Am J Ind Med. 1999;36:135–141. doi: 10.1002/(sici)1097-0274(199907)36:1<135::aid-ajim19>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- 11.Acquavella J, Olsen G, Cole P, et al. Cancer among Farmers: A Meta-Analysis. Ann Epidemiol. 1998;8:64–74. doi: 10.1016/s1047-2797(97)00120-8. [DOI] [PubMed] [Google Scholar]
- 12.Blair A, Freeman LB. Epidemiologic studies of cancer in agricultural populations: Observations and future directions. J Agromedicine. 2009;14:125–131. doi: 10.1080/10599240902779436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Alavanja MCR, Sandler DP, Lynch CF, et al. Cancer incidence in the Agricultural Health Study. Scand J Work Environ Health. 2005;31(suppl):39–45. [PubMed] [Google Scholar]
- 14.Alavanja MC, Ross MK, Bonner MR. Increased cancer burden among pesticide applicators and others due to pesticide exposure. CA Cancer J Clin. 2013;63:120–142. doi: 10.3322/caac.21170. [DOI] [PubMed] [Google Scholar]
- 15.International Agency for Research on Cancer. IARC Monograph on the Evaluation of Carcinogenic Risk to Humans. Vol. 53. Lyon, France: IARC; 1991. Occupational Exposures in Insecticide Applications, and Some Pesticides. [Google Scholar]
- 16.Boers D, Portengen L, Bas Bueno-de-Mesquita H, Heederik D, Vermeulen R. Cause-specific mortality of Dutch chlorophenoxy herbicide manufacturing workers. Occup Environ Med. 2010;67:24–31. doi: 10.1136/oem.2008.044222. [DOI] [PubMed] [Google Scholar]
- 17.Koutros S, Lynch CF, Ma X, et al. Heterocyclic aromatic amine pesticide use and human cancer risk: Results from the U.S. Agricultural Health Study. Int J Cancer. 2009;124:1206–1212. doi: 10.1002/ijc.24020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rusiecki JA, De Roos A, Lee WJ, et al. Cancer Incidence Among Pesticide Applicators Exposed to Atrazine in the Agricultural Health Study. J Natl Cancer Inst. 2004;96:1375–1382. doi: 10.1093/jnci/djh264. [DOI] [PubMed] [Google Scholar]
- 19.Viel JF, Challier B. Bladder cancer among french farmers: Does exposure to pesticides in vineyards play a part? Occup Environ Med. 1995;52:587–592. doi: 10.1136/oem.52.9.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Koutros S, Alavanja MCR, Lubin JH, et al. An update of cancer incidence in the agricultural health study. J Occup Environl Medicine. 2010;52:1098–1105. doi: 10.1097/JOM.0b013e3181f72b7c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Rusiecki JA, Patel R, Koutros S, et al. Cancer incidence among pesticide applicators exposed to permethrin in the agricultural health study. Environ Health Perspect. 2009;117:581–586. doi: 10.1289/ehp.11318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Choi YJ, Seelbach MJ, Pu H. Polychlorinated biphenyls disrupt intestinal integrity via NADPH oxidase-induced alterations of tight junction protein expression. Environ Health Perspect. 2010;118:976–981. doi: 10.1289/ehp.0901751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Banerjee BD, Seth V, Ahmed RS. Pesticide induced oxidative stress: perspectives and trends. Rev Environ Health. 2001;16:1–40. doi: 10.1515/reveh.2001.16.1.1. [DOI] [PubMed] [Google Scholar]
- 24.Koutros S, Andreotti G, Berndt SI, et al. Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer. Pharmacogenet Genomics. 2011;21:615–623. doi: 10.1097/FPC.0b013e3283493a57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Savic-Radojevic A, Djukic T, Simic T, et al. GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer. Redox Rep. 2013;18:1–7. doi: 10.1179/1351000212Y.0000000031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ding G, Liu F, Shen B, Feng C, Xu J, Ding Q. The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality. Clin Genitourin Cancer. 2012;10:251–255. doi: 10.1016/j.clgc.2012.08.001. [DOI] [PubMed] [Google Scholar]
- 27.Siegel D, Gustafson DL, Dehn DL, et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol. 2004;65:1238–1247. doi: 10.1124/mol.65.5.1238. [DOI] [PubMed] [Google Scholar]
- 28.Joseph P, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA. 1994;91:8413–8417. doi: 10.1073/pnas.91.18.8413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rosenblum JS, Gilula NB, Lerner RA. On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA. 1996;93:4471–4473. doi: 10.1073/pnas.93.9.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Traver RD, Siegel D, Beall HD, et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase) Br J Cancer. 1997;75:69–75. doi: 10.1038/bjc.1997.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sutton A, Imbert A, Igoudjil A, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics. 2005;15:311–319. doi: 10.1097/01213011-200505000-00006. [DOI] [PubMed] [Google Scholar]
- 32.Guo ZJ, Feng CL. The NQO1 rs1800566 Polymorphism and Risk of Bladder Cancer: Evidence from 6,169 Subjects. Asian Pacific J Cancer Prev. 2012;13:6343–6348. doi: 10.7314/apjcp.2012.13.12.6343. [DOI] [PubMed] [Google Scholar]
- 33.Wang YH, Lee YH, Tseng PT, Shen CH, Chiou HY. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan. J Cancer Res Clin Oncol. 2008;134:203–209. doi: 10.1007/s00432-007-0271-4. [DOI] [PubMed] [Google Scholar]
- 34.Cengiz M, Ozaydin A, Ozkilic AC, Dedekarginoglu G. The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol. 2007;39:1043–1048. doi: 10.1007/s11255-007-9179-9. [DOI] [PubMed] [Google Scholar]
- 35.Chao C, Zhang Z-F, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:979–987. doi: 10.1158/1055-9965.EPI-05-0899. [DOI] [PubMed] [Google Scholar]
- 36.Terry PD, Umbach DM, Taylor JA. No association between SOD2 or NQO1 genotypes and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:753–754. doi: 10.1158/1055-9965.EPI-04-0574. [DOI] [PubMed] [Google Scholar]
- 37.Moore LE, Wiencke JK, Bates MN, Zheng S, Rey OA, Smith AH. Investigation of genetic polymorphisms and smoking in a bladder cancer case–control study in Argentina. Cancer Letters. 2004;211:199–207. doi: 10.1016/j.canlet.2004.04.011. [DOI] [PubMed] [Google Scholar]
- 38.Hung RJ, Boffetta P, Brennan P, et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004;25:973–978. doi: 10.1093/carcin/bgh080. [DOI] [PubMed] [Google Scholar]
- 39.Xu LL, Wain JC, Miller DP, et al. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior. Cancer Epidemiol Biomarkers Prev. 2001;10:303–309. [PubMed] [Google Scholar]
- 40.Peluso M, Airoldi L, Magagnotti C, et al. White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis. 2000;21:183–187. doi: 10.1093/carcin/21.2.183. [DOI] [PubMed] [Google Scholar]
- 41.Schulz WA, Krummeck A, Rosinger I, et al. Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics. 1997;7:235–239. doi: 10.1097/00008571-199706000-00008. [DOI] [PubMed] [Google Scholar]
- 42.Zheng YL, Amr S, Saleh DA, et al. Urinary bladder cancer risk factors in egypt: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21:537–546. doi: 10.1158/1055-9965.EPI-11-0589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Goerlitz D, Amr S, Dash C, et al. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt. Urol Oncol. doi: 10.1016/j.urolonc.2013.06.016. Accepted for publication. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dich J, Zahm SH, Hanberg A, Adami HO. Pesticides and cancer. Cancer Causes Control. 1997;8:420–443. doi: 10.1023/a:1018413522959. [DOI] [PubMed] [Google Scholar]
- 45.Ezzat S, Abdel-Hamid M, Abdel-Latif ES, et al. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health. 2005;208:329–339. doi: 10.1016/j.ijheh.2005.04.003. [DOI] [PubMed] [Google Scholar]
- 46.Kogevinas M, Becher H, Benn T, et al. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol. 1997;145:1061–1075. doi: 10.1093/oxfordjournals.aje.a009069. [DOI] [PubMed] [Google Scholar]
- 47.Kang D, Lee KM, Park SK, et al. Functional Variant of Manganese Superoxide Dismutase (SOD2 V16A) Polymorphism Is Associated with Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Study. Cancer Epidemiol Biomarkers Prev. 2007;16:1581–1586. doi: 10.1158/1055-9965.EPI-07-0160. [DOI] [PubMed] [Google Scholar]
- 48.Polytarchou C, Hatziapostolou M, Papadimitriou E. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem. 2005;49:40428–40435. doi: 10.1074/jbc.M505120200. [DOI] [PubMed] [Google Scholar]
- 49.Wenk J, Brnneisen P, Wlaschek M, et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem. 1999;274:25869–25876. doi: 10.1074/jbc.274.36.25869. [DOI] [PubMed] [Google Scholar]
- 50.Wiencke JK, Pemble S, Ketterer B, et al. Gene deletion of glutathione S-transferase: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev. 1995;4:253–259. [PubMed] [Google Scholar]
- 51.Kelsey KT, Spitz MR, Zuo ZF, et al. Polymorphisms in the glutathione S-transferase class and genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States) Cancer Causes Control. 1997;8:554–559. doi: 10.1023/a:1018434027502. [DOI] [PubMed] [Google Scholar]
- 52.Wolpert BJ, Amr S, Saleh DA, et al. Associations differ by sex for catechol-O-methyltransferase genotypes and bladder cancer risk in South Egypt. Urol Oncol. 2012;30:841–847. doi: 10.1016/j.urolonc.2010.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]